Nausea, vomiting, constipation, stomach pain, and other digestive symptoms are higher-risk situations
Genetic analyses have demonstrated that MASLD is a heterogeneous disorder driven by multiple molecular mechanisms rather than a single pathogenic pathway
The ADAs 2026 update discusses GLP-1 RA effects on eye health including potential impacts on diabetic retinopathy progression, glaucoma, and macular degeneration
39 GLP-1RAs and Coronary Artery Disease Epicardial CAD is commonly seen in HFpEF
And so what I feel like I'm going to do is I'm going to start reducing down either in the number of days or in the amount of GLP-1
Previous research has demonstrated increased amino acid catabolism in skeletal muscle with low glycogen content, and further research is needed to determine if skeletal muscle loss in patients taking GLP-1RA can be mitigated through synergistic pharmaceutical or dietary interventions to maximize skeletal muscle glycogen content [165]